EI
RDY icon

Ethic Inc’s Dr. Reddy's Laboratories RDY Stock Holding History

Ethic Inc’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91M Buy
132,074
+12,047
+10% +$163K 0.02% 518
2026
Q1 		$1.66M Buy
120,027
+20,074
+20% +$279K 0.03% 506
2025
Q4 		$1.4M Buy
99,953
+74,528
+293% +$1.05M 0.02% 546
2025
Q3 		$355K Buy
25,425
+6,909
+37% +$99.4K 0.01% 952
2025
Q2 		$279K Buy
18,516
+427
+2% +$6.1K 0.01% 1004
2025
Q1 		$238K Sell
18,089
-4,984
-22% -$68.8K ﹤0.01% 1016
2024
Q4 		$364K Buy
23,073
+983
+4% +$14.8K 0.01% 886
2024
Q3 		$324K Sell
22,090
-7,460
-25% -$120K 0.01% 863
2024
Q2 		$450K Buy
29,550
+7,460
+34% +$107K 0.01% 787
2024
Q1 		$324K Buy
22,090
+2,010
+10% +$29.3K 0.01% 862
2023
Q4 		$279K Buy
20,080
+1,175
+6% +$15.7K 0.01% 896
2023
Q3 		$253K Buy
18,905
+2,870
+18% +$38.8K 0.01% 862
2023
Q2 		$202K Buy
+16,035
New +$187K 0.01% 909
2022
Q3 		– Sell
-19,985
Closed -$221K – 830
2022
Q2 		$221K Buy
+19,985
New +$217K 0.02% 698

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ethic Inc's RDY Position: Q2 2026 in Review

Ethic Inc increased its Dr. Reddy's Laboratories (RDY) stake by 10% in Q2 2026, buying an estimated $163K and bringing the position to 132,074 shares worth $1.91M. The position accounts for 0.02% of the portfolio, ranked #518.

Ethic Inc first reported a position in RDY in Q2 2022 and has held it in 14 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Ethic Inc held 132,074 shares of Dr. Reddy's Laboratories worth $1.91M as of Q2 2026.
  • Ethic Inc bought 12,047 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $163K.
  • Dr. Reddy's Laboratories made up 0.02% of Ethic Inc's portfolio in Q2 2026, its #518 holding.
  • Ethic Inc first reported a position in Dr. Reddy's Laboratories in Q2 2022 and has held it in 14 quarters since.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.